NDC 25021-669

Cisatracurium Besylate

Cisatracurium Besylate

Cisatracurium Besylate is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Cisatracurium Besylate.

Product ID25021-669_267afcd0-cc18-4395-b5cf-5adf012fb9a7
NDC25021-669
Product TypeHuman Prescription Drug
Proprietary NameCisatracurium Besylate
Generic NameCisatracurium Besylate
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-12-01
Marketing CategoryANDA / ANDA
Application NumberANDA201836
Labeler NameSagent Pharmaceuticals
Substance NameCISATRACURIUM BESYLATE
Active Ingredient Strength10 mg/mL
Pharm ClassesNeuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 25021-669-20

1 VIAL in 1 CARTON (25021-669-20) > 20 mL in 1 VIAL
Marketing Start Date2021-11-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 25021-669-20 [25021066920]

Cisatracurium Besylate INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA201836
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-12-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
CISATRACURIUM BESYLATE10 mg/mL

Pharmacological Class

  • Neuromuscular Nondepolarizing Blockade [PE]
  • Nondepolarizing Neuromuscular Blocker [EPC]

NDC Crossover Matching brand name "Cisatracurium Besylate" or generic name "Cisatracurium Besylate"

NDCBrand NameGeneric Name
0409-1098Cisatracurium BesylateCISATRACURIUM BESYLATE
0409-1103Cisatracurium BesylateCISATRACURIUM BESYLATE
70069-151Cisatracurium BesylateCisatracurium Besylate
70069-141Cisatracurium BesylateCisatracurium Besylate
0703-2045Cisatracurium BesylateCisatracurium Besylate
0703-2033Cisatracurium BesylateCisatracurium Besylate
0703-2056Cisatracurium BesylateCisatracurium Besylate
0781-3150cisatracurium besylatecisatracurium besylate
0781-3152cisatracurium besylatecisatracurium besylate
0781-3153cisatracurium besylatecisatracurium besylate
0781-9037cisatracurium besylatecisatracurium besylate
0781-9038cisatracurium besylatecisatracurium besylate
0781-9039cisatracurium besylatecisatracurium besylate
57884-3061CISATRACURIUM BESYLATECISATRACURIUM BESYLATE
57884-3063CISATRACURIUM BESYLATECISATRACURIUM BESYLATE
57884-3062CISATRACURIUM BESYLATECISATRACURIUM BESYLATE
70069-161Cisatracurium BesylateCisatracurium Besylate
71288-712Cisatracurium BesylateCisatracurium Besylate
71288-713Cisatracurium BesylateCisatracurium Besylate
71288-714Cisatracurium BesylateCisatracurium Besylate
25021-669Cisatracurium BesylateCisatracurium Besylate
25021-668Cisatracurium BesylateCisatracurium Besylate
25021-670Cisatracurium BesylateCisatracurium Besylate
70710-1532cisatracurium besylatecisatracurium besylate
70710-1534cisatracurium besylatecisatracurium besylate
72785-0009cisatracurium besylatecisatracurium besylate
72785-0008cisatracurium besylatecisatracurium besylate
0409-1208Cisatracurium BesylateCisatracurium Besylate
72785-0011cisatracurium besylatecisatracurium besylate
23155-768Cisatracurium BesylateCisatracurium Besylate
55150-286Cisatracurium BesylateCisatracurium Besylate
55150-284Cisatracurium besylateCisatracurium besylate
0074-4378NimbexCisatracurium besylate
0074-4380NimbexCisatracurium besylate
0074-4382NimbexCisatracurium besylate
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.